Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
PI3Kδ: Too much of a good thing.

Nature immunology

Kennedy DE, Clark MR.
PMID: 30127436
Nat Immunol. 2018 Sep;19(9):910-911. doi: 10.1038/s41590-018-0183-2.

No abstract available.

Cite
Kennedy DE, Clark MR. PI3Kδ: Too much of a good thing. Nat Immunol. 2018;19(9):910-911doi: 10.1038/s41590-018-0183-2.
Kennedy, D. E., & Clark, M. R. (2018). PI3Kδ: Too much of a good thing. Nature immunology, 19(9), 910-911. https://doi.org/10.1038/s41590-018-0183-2
Kennedy, Domenick E, and Clark, Marcus R. "PI3Kδ: Too much of a good thing." Nature immunology vol. 19,9 (2018): 910-911. doi: https://doi.org/10.1038/s41590-018-0183-2
Kennedy DE, Clark MR. PI3Kδ: Too much of a good thing. Nat Immunol. 2018 Sep;19(9):910-911. doi: 10.1038/s41590-018-0183-2. PMID: 30127436.
Copy Download .nbib Format: NLM
Natural immune response and protection from SARS-CoV-2 reinfection.

Acta virologica

Margiotti K, Fabiani M, Mesoraca A, Giorlandino C.
PMID: 34796710
Acta Virol. 2021;65(4):333-338. doi: 10.4149/av_2021_401.

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated disease Coronavirus disease 2019 (COVID-19) continues to spread throughout the world, causing millions of infections and dead. One major question in predicting the course of the COVID-19...

Cite
Margiotti K, Fabiani M, Mesoraca A, et al. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol. 2021;65(4):333-338doi: 10.4149/av_2021_401.
Margiotti, K., Fabiani, M., Mesoraca, A., & Giorlandino, C. (2021). Natural immune response and protection from SARS-CoV-2 reinfection. Acta virologica, 65(4), 333-338. https://doi.org/10.4149/av_2021_401
Margiotti, Katia, et al. "Natural immune response and protection from SARS-CoV-2 reinfection." Acta virologica vol. 65,4 (2021): 333-338. doi: https://doi.org/10.4149/av_2021_401
Margiotti K, Fabiani M, Mesoraca A, Giorlandino C. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol. 2021;65(4):333-338. doi: 10.4149/av_2021_401. PMID: 34796710.
Copy Download .nbib Format: NLM
Humoral Immunity in Heart Failure.

Cardiovascular & hematological disorders drug targets

Sarkar A, Rafiq K.
PMID: 29773070
Cardiovasc Hematol Disord Drug Targets. 2019;19(1):14-18. doi: 10.2174/1871529X18666180518101527.

Cardiovascular Disease (CVD) is a class of diseases that involve disorders of heart and blood vessels, including hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, which finally lead to Heart Failure (HF). There are several treatments available all...

Cite
Sarkar A, Rafiq K. Humoral Immunity in Heart Failure. Cardiovasc Hematol Disord Drug Targets. 2019;19(1):14-18doi: 10.2174/1871529X18666180518101527.
Sarkar, A., & Rafiq, K. (2019). Humoral Immunity in Heart Failure. Cardiovascular & hematological disorders drug targets, 19(1), 14-18. https://doi.org/10.2174/1871529X18666180518101527
Sarkar, Amrita, and Rafiq, Khadija. "Humoral Immunity in Heart Failure." Cardiovascular & hematological disorders drug targets vol. 19,1 (2019): 14-18. doi: https://doi.org/10.2174/1871529X18666180518101527
Sarkar A, Rafiq K. Humoral Immunity in Heart Failure. Cardiovasc Hematol Disord Drug Targets. 2019;19(1):14-18. doi: 10.2174/1871529X18666180518101527. PMID: 29773070.
Copy Download .nbib Format: NLM
Natural immune response and protection from SARS-CoV-2 reinfection.

Acta virologica

Margiotti K, Fabiani M, Mesoraca A, Giorlandino C.
PMID: 34796710
Acta Virol. 2021;65(4):333-338. doi: 10.4149/av_2021_401.

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated disease Coronavirus disease 2019 (COVID-19) continues to spread throughout the world, causing millions of infections and dead. One major question in predicting the course of the COVID-19...

Cite
Margiotti K, Fabiani M, Mesoraca A, et al. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol. 2021;65(4):333-338doi: 10.4149/av_2021_401.
Margiotti, K., Fabiani, M., Mesoraca, A., & Giorlandino, C. (2021). Natural immune response and protection from SARS-CoV-2 reinfection. Acta virologica, 65(4), 333-338. https://doi.org/10.4149/av_2021_401
Margiotti, Katia, et al. "Natural immune response and protection from SARS-CoV-2 reinfection." Acta virologica vol. 65,4 (2021): 333-338. doi: https://doi.org/10.4149/av_2021_401
Margiotti K, Fabiani M, Mesoraca A, Giorlandino C. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol. 2021;65(4):333-338. doi: 10.4149/av_2021_401. PMID: 34796710.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries